Nanomedical Diagnostics Announces Raise of $1.6MM in Series A Funding

Nanomedical Diagnostics, a Serra Capital II portfolio company, was featured on news.gnom.es on October 13. Nanomedical Diagnostics is a biotech company developing and commercializing bioelectronics for use in research and diagnostics. The company announced the completion of a Series A financing round of $1.6 million, which was led by Serra Ventures.

Tim Hoerr, CEO of Serra Ventures, was quoted enthusing “This company is applying a very novel and powerful technology to a current hot issue– personalized healthcare. Nanomed has a bold, expansive vision, but the team has built interim products and revenue opportunities on the road to their end goal of putting information in people’s hands to make educated health choices.”

Source: http://news.gnom.es/pr/nanomedical-diagnos...